Related Experiment Videos
Treatment of severe malaria
1Nuffield Department of Clinical Medicine, University of Oxford.
Journal of the Royal Society of Medicine
|January 1, 1989
Summary
For severe malaria, intravenous antimalarials are crucial until oral medication is possible. Quinine is preferred for chloroquine-resistant Plasmodium falciparum, with quinidine as an alternative, while chloroquine is effective for sensitive strains.
Area of Science:
- Infectious Diseases
- Tropical Medicine
- Pharmacology
Background:
- Severe Plasmodium falciparum malaria requires prompt and effective treatment.
- Intravenous antimalarial drug administration is preferred for severe cases until oral intake is feasible.
- Drug resistance patterns influence treatment choices.
Purpose of the Study:
- To outline optimal antimalarial drug strategies for severe Plasmodium falciparum infections.
- To discuss alternative treatments and supportive care measures.
- To highlight the importance of considering drug resistance and patient status.
Main Methods:
- Review of current treatment guidelines for severe malaria.
- Discussion of drug efficacy, administration routes, and resistance profiles.
- Emphasis on supportive care, including fluid management and complication treatment.
Main Results:
- Quinine is the primary choice for chloroquine-resistant or uncertain malaria; quinidine is a parenteral alternative.
- Chloroquine can be effective and safer for chloroquine-sensitive Plasmodium falciparum.
- Supportive care is vital, addressing complications like anemia, shock, and fluid imbalances.
Conclusions:
- Intravenous antimalarial therapy is essential for severe falciparum malaria.
- Treatment selection must account for Plasmodium falciparum drug resistance.
- Comprehensive supportive care is critical for patient survival and recovery.